Buscar
Mostrando ítems 1-10 de 719
Making Targeted Therapy Compatible with Checkpoint Immunotherapy
(Elsevier Science London, 2017-07)
Immune checkpoint blockades induced by antibodies are revolutionizing cancer therapy. Combinations of checkpoint immunotherapies with kinase inhibitors (KIs) are being clinically evaluated as oncogenic mutations arise. ...
Cancer immunotherapy: lessons from the parasites to improve fighting against tumors
(AME Publishing Company, 2020)
Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy
(Springer Science and Business Media Deutschland GmbH, 2020-10-28)
Immunotherapy has been one of the great advances in the recent years for the treatment of advanced tumors, with nonsmall-cell lung cancer (NSCLC) being one of the cancers that has benefited most from this approach. Currently, ...
An integrative model of cancer cell differentiation with immunotherapy
(IOP Publishing, 2021-10)
In order to improve cancer treatments, cancer cell differentiation and immunotherapy are the subjects of several studies in different branches of interdisciplinary sciences. In this work, we develop a new population model ...
Cancer Immunotherapy: Lights and Shadows
(Frontiers Research, 2015-07)
Cancer immunotherapy has recently emerged as the fourth treatment modality, in addition to surgery, chemotherapy, and radiotherapy. These advances are the result of important discoveries in the field of regulation of the ...
CD133 in breast cancer cells and in breast cancer stem cells as another target for immunotherapy
(Elsevier, 2016)
Breast cancer consists of a heterogeneous group of tumors with different features, biology and treatments. Cancer stem cells (CSCs) have been associated with an aggressive cellular behavior, resistance to chemotherapy and ...
Classification of current anticancer immunotherapies
(Impact Journals, 2014-12-18)
During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and ...
Recent advances and future of immunotherapy for glioblastoma
(Informa Healthcare, 2016-10)
Introduction: Outcome for glioma (GBM) remains dismal despite advances in therapeutic interventions including chemotherapy, radiotherapy and surgical resection. The overall survival benefit observed with immunotherapies ...
Modeling cancer immunotherapy: Assessing the effects of lymphocytes on cancer cell growth and motility
(Elsevier Science, 2013-02)
A mesoscopic model is used to describe the effects of lymphocyte activity on a growing tumor. The model yields novel insights into the tumor–immune system interaction. In particular, we found that the presence of a putative ...